The speculation over who will replace long-serving AbbVie chief executive Richard Gonzalez is over, as the company confirms that president and chief operating officer Robert Michael will take the ...

Richard A. Gonzalez is the founder of AbbVie Ltd. (United Kingdom) since 2013, holding the title of Chairman & Chief Executive Officer. Current jobs include Chief Executive Officer at AbbVie ...

AbbVie’s CEO Richard Gonzalez took a huge bet that Rova-T would be the next big thing in oncology. Rova-T had a convincing-looking mechanism of action, consisting of an antibody that locks onto ...

AbbVie recently secured FDA approval for RINVOQ to treat giant cell arteritis, which alongside a biologics license application for TrenibotE, underscored the company's focus on innovation.

Richard Gere revealed the only way fans would get a sequel to his and Julia Roberts’ 1990 rom-com “Pretty Woman” is if the writing was up to par. “It all comes down to whether or not there ...

Richard Gere and his wife Alejandra Silva are already planning on moving back to the U.S. after relocating to Madrid at the end of 2024. At the 2025 Gala: Carnaval in New York City, Alejandra ...

After a 2024 in which AbbVie’s Skyrizi boasted the highest TV drug ad spending outlay on seven of our monthly roundups—and took second place in four more—the immunology med has seen that ...

An AbbVie research and development lab in San Francisco. (Brian L. Frank for The Wall Street Journal) Drugmaker AbbVie plans to invest more than $10 billion in domestic manufacturing and other ...

Olympic medalist and Stoughton, Massachusetts native Frederick Richard may have broken the world record for the most backflips done in 24 hours. Known as "Frederick Flips" on social media ...

Shares of AbbVie (ABBV) appear to be overbought. The recent move higher may pause or even end. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform—now 60% off ...

These two policies could have major impacts on AbbVie, Lilly, and Johnson & Johnson. Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market ...

Also Read: AbbVie’s Pipeline May Be A 2026 Story, But Analyst Likes The Setup Now On Friday, AbbVie reported an adjusted EPS of $2.46, up 6.5% year over year and beating the consensus of $2.38.